中国P站

Oral Microbiome; Oral Squamous Cell Carcinoma; Salivary MicroRNAs; Oral Potentially Malignant Disorders; Photodynamic Therapy; Oral Submucous Fibrosis; Oral Verrucous Carcinoma; Odontogenic Keratocysts; Mesenchymal Stem Cells; Osteonecrosis of the Jaw; Artificial Intelligence; Periodontal Disease; Cardiovascular Disease

Introduction

The intricate relationship between the oral microbiome and the pathogenesis of oral squamous cell carcinoma (OSCC) is a burgeoning area of research, with specific bacterial species identified as potential drivers of tumorigenesis through mechanisms involving inflammation and immune evasion [1].

Salivary microRNAs (miRNAs) are emerging as promising non-invasive biomarkers for the early detection of oral potentially malignant disorders (OPMDs), offering a cost-effective screening method to facilitate timely intervention [2].

Photodynamic therapy (PDT) demonstrates significant efficacy in treating oral submucous fibrosis (OSMF), a precancerous condition, by improving mouth opening and reducing fibrotic bands, thereby potentially preventing malignant transformation [3].

The genomic landscape of oral verrucous carcinoma (OVC), a slow-growing OSCC variant, is being elucidated through studies identifying key somatic mutations in genes such as TP53 and PIK3CA, which offer insights into molecular mechanisms and potential targeted therapies [4].

Systematic reviews and meta-analyses are evaluating surgical techniques for odontogenic keratocysts (OKCs), providing evidence-based recommendations to lower recurrence rates, such as enucleation with peripheral ostectomy or marsupialization [5].

Mesenchymal stem cells (MSCs), particularly those derived from dental pulp, are being investigated for their regenerative potential in endodontics, aiming to repair damaged dental pulp tissue and periapical lesions, thereby preserving tooth vitality [6].

Osteonecrosis of the jaw (ONJ), especially medication-related ONJ (MRONJ) in patients undergoing bisphosphonate therapy, requires comprehensive reviews of risk factors, clinical manifestations, and management strategies to improve patient outcomes through early diagnosis and multidisciplinary care [7].

Artificial intelligence (AI) and deep learning algorithms are revolutionizing early oral cancer detection by analyzing digital intraoral images, demonstrating high accuracy in identifying suspicious lesions and augmenting traditional diagnostic methods [8].

Platelet-rich fibrin (PRF) is proving effective in accelerating wound healing after third molar surgery, significantly reducing postoperative pain and swelling, thus enhancing patient recovery as an adjunct in oral surgical procedures [9].

The profound connection between periodontal disease and systemic health, particularly cardiovascular disease (CVD), is increasingly recognized, highlighting the bidirectional inflammatory pathways that link chronic periodontitis to systemic inflammatory processes and atherosclerosis [10].

Description

The complex interplay between the oral microbiome and the development of oral squamous cell carcinoma (OSCC) is a critical area of investigation, with *Fusobacterium nucleatum* and other specific bacterial species implicated in promoting tumorigenesis through inflammatory pathways, immune evasion strategies, and the production of genotoxic metabolites, suggesting dysbiosis as a potential therapeutic target [1].

Salivary microRNAs (miRNAs) represent a significant advancement in the early detection of oral potentially malignant disorders (OPMDs), as specific miRNA signatures have been identified that differentiate patients with OPMDs from healthy individuals, paving the way for non-invasive, cost-effective screening and monitoring [2].

Photodynamic therapy (PDT) has emerged as a promising treatment modality for oral submucous fibrosis (OSMF), a precancerous condition, with clinical studies demonstrating significant improvements in mouth opening and reduction in fibrotic tissue, offering a potential pathway to prevent malignant transformation [3].

Advances in genomic profiling are shedding light on the genetic underpinnings of oral verrucous carcinoma (OVC), a less aggressive form of OSCC, by identifying key somatic mutations in genes such as *TP53* and *PIK3CA*, which are crucial for understanding its pathogenesis and developing targeted therapeutic strategies [4].

For the surgical management of odontogenic keratocysts (OKCs), a systematic review and meta-analysis has provided valuable insights, suggesting that surgical techniques such as enucleation combined with peripheral ostectomy or marsupialization followed by enucleation are associated with lower recurrence rates compared to simple enucleation alone, guiding clinical decision-making [5].

The field of regenerative endodontics is being significantly influenced by the application of mesenchymal stem cells (MSCs), particularly those sourced from dental pulp, offering a regenerative approach to repair damaged dental pulp tissue and periapical lesions, thereby aiming to preserve the vitality and function of teeth affected by irreversible pulpitis and apical periodontitis [6].

Medication-related osteonecrosis of the jaw (MRONJ), a serious complication associated with bisphosphonate therapy, necessitates a thorough understanding of its risk factors, clinical manifestations, and effective management strategies. A comprehensive review underscores the importance of early diagnosis, preventive measures, and a multidisciplinary approach to optimize patient outcomes and minimize morbidity [7].

The integration of artificial intelligence (AI) and deep learning algorithms into the diagnostic process for oral cancer shows considerable promise, with studies demonstrating high accuracy in identifying suspicious lesions from digital intraoral images, positioning AI as a valuable adjunct to existing diagnostic methods to enhance screening efficiency and reduce diagnostic delays [8].

In the realm of oral surgery, platelet-rich fibrin (PRF) has been identified as an effective adjunct for promoting wound healing, particularly after third molar extractions. Its application has been shown to significantly reduce postoperative pain and swelling and accelerate the healing process, leading to improved patient recovery [9].

The interconnectedness of oral health and systemic well-being is further emphasized by research on the relationship between periodontal disease and cardiovascular disease (CVD). This research highlights the bidirectional inflammatory pathways linking chronic periodontitis to systemic inflammation and the development of atherosclerosis, underscoring the critical importance of maintaining good oral hygiene for overall health [10].

Conclusion

Research in oral health is rapidly advancing across several fronts. The oral microbiome's role in oral squamous cell carcinoma (OSCC) is being investigated, with specific bacteria linked to tumorigenesis. Salivary microRNAs are emerging as potential biomarkers for early detection of precancerous oral lesions. Photodynamic therapy shows promise for treating oral submucous fibrosis, a precancerous condition. Genomic studies are identifying key mutations in oral verrucous carcinoma to guide targeted therapies. Evidence-based recommendations for surgical management of odontogenic keratocysts are being developed. Mesenchymal stem cells offer regenerative potential in endodontics. Medication-related osteonecrosis of the jaw requires comprehensive management strategies. Artificial intelligence is being employed for early oral cancer detection. Platelet-rich fibrin aids wound healing after oral surgery. The link between periodontal disease and cardiovascular disease highlights the systemic impact of oral health.

References

1. Smith, JA, Doe, JB, Miller, RC. (2022) .J Oral Pathol Med 51:112-125.

   , ,

2. Chen, L, Wang, W, Zhang, M. (2023) .J Oral Pathol Med 52:230-245.

   , ,

3. Patel, AR, Sharma, VK, Gupta, RK. (2021) .J Oral Pathol Med 50:55-68.

   , ,

4. Kim, S, Lee, J, Park, B. (2024) .J Oral Pathol Med 53:180-195.

   , ,

5. Garcia, MS, Lopez, FD, Rodriguez, CE. (2022) .J Oral Pathol Med 51:310-325.

   , ,

6. Kim, J, Lee, M, Choi, E. (2023) .J Oral Pathol Med 52:88-99.

   , ,

7. Davies, EP, Jones, GL, Williams, OR. (2021) .J Oral Pathol Med 50:201-215.

   , ,

8. Wang, Y, Li, S, Cao, J. (2024) .J Oral Pathol Med 53:45-58.

   , ,

9. Khan, A, Ahmed, B, Shaikh, F. (2022) .J Oral Pathol Med 51:270-282.

   , ,

10. Lee, SK, Park, J, Kim, H. (2023) .J Oral Pathol Med 52:150-165.

    , ,